WeVote

Bill

Bill

LC 4182

Establish the Montana rare disease advisory council

2025 Regular Session

Montana establishes rare disease advisory council to coordinate diagnosis, treatment access, and support for patients with rare genetic disorders statewide.

(LC) Draft Ready for Delivery
0
WeVote Research Nonpartisan
Bill Summary · LC 4182

Legislative bill overview

LC 4182 would establish a Montana Rare Disease Advisory Council to coordinate statewide efforts addressing rare diseases and genetic disorders. The council would likely bring together healthcare providers, patient advocates, researchers, and state officials to improve diagnosis, treatment access, and support services for Montanans with rare conditions.

Why is this important

Rare diseases affect millions of Americans but often lack adequate research funding, clinical expertise, and patient support infrastructure. Montana residents with rare diseases frequently face diagnostic delays, limited treatment options, and difficulty accessing specialists—establishing a coordinated advisory body could help identify gaps and improve outcomes for an underserved population.

Potential points of contention

  • Resource allocation: Creating and staffing a new advisory council requires state funding; critics may question whether resources should go directly to healthcare services instead
  • Scope and authority: Unclear whether the council will have advisory-only powers or decision-making authority affecting insurance coverage, Medicaid policy, or research funding priorities
  • Geographic challenges: Montana's rural nature may make centralized coordination difficult; implementation could favor urban areas where specialists concentrate

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.